In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
The description of how the system works to attack cancer cells sounds absolutely incredible. The scientists used the nanoparticles to send a message to the CRISPR enzyme Cas9 to target cancer ...
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback